The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $131.29

Today's change+1.02 +0.78%
Updated July 1 4:02 PM EDT. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $131.29

Today's change+1.02 +0.78%
Updated July 1 4:02 PM EDT. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings up (U.S.)$1.02

Laboratory Corporation of America Holdings closed up Friday by (U.S.)$1.02 or 0.78% to (U.S.)$131.29. Over the last five days, shares have gained 1.29% and 6.19% year to date. Shares have outperformed the S&P 500 by 6.22% during the last year.

Key company metrics

  • Open(U.S.) $130.48
  • Previous close(U.S.) $130.27
  • High(U.S.) $131.37
  • Low(U.S.) $129.68
  • Bid / Ask-- / --
  • YTD % change+6.19%
  • Volume976,181
  • Average volume (10-day)1,266,224
  • Average volume (1-month)934,972
  • Average volume (3-month)925,025
  • 52-week range(U.S.) $97.79 to (U.S.) $131.99
  • Beta0.87
  • Trailing P/E22.70×
  • P/E 1 year forward14.93×
  • Forward PEG1.48×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.78
Updated July 1 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.45%

Based on its net profit margin of 6.45%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,3682,3012,3172,269
Total other revenue--------
Total revenue2,3682,3012,3172,269
Gross profit777741763775
Total cost of revenue1,5911,5601,5541,495
Total operating expense2,0662,0572,0101,948
Selling / general / administrative412405383392
Research & development--------
Depreciation / amortization44384747
Interest expense (income), net operating--------
Unusual expense (income)19542614
Other operating expenses, total--------
Operating income302243307321
Interest income (expense), net non-operating-55-57-56-58
Gain (loss) on sale of assets--------
Other--------
Income before tax256186250264
Income after tax161115153169
Income tax, total96729796
Net income160114153168
Total adjustments to net income--------
Net income before extra. items160114153168
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items160114153168
Inc. avail. to common incl. extra. items160114153168
Diluted net income161114153168
Dilution adjustment0--00
Diluted weighted average shares104103103103
Diluted EPS excluding extraordinary itemsvalue per share1.551.111.481.64
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.671.431.641.73